scispace - formally typeset
C

Chom-Kyu Chong

Researcher at Dankook University

Publications -  56
Citations -  740

Chom-Kyu Chong is an academic researcher from Dankook University. The author has contributed to research in topics: Acetolactate synthase & Monoclonal antibody. The author has an hindex of 15, co-authored 55 publications receiving 640 citations. Previous affiliations of Chom-Kyu Chong include Chungbuk National University & Chinese Academy of Sciences.

Papers
More filters
Journal ArticleDOI

Smartphone-Based Fluorescent Diagnostic System for Highly Pathogenic H5N1 Viruses

TL;DR: In this paper, a smartphone-based fluorescent diagnostic device with an efficient reflective light collection module using a coumarin-derived dendrimer based fluorescent lateral flow immunoassay was used to detect avian influenza.
Journal ArticleDOI

Amino Acid Residues Conferring Herbicide Tolerance in Tobacco Acetolactate Synthase

TL;DR: The results suggest that two residues Ala121 and Ser652 are potent residues conferring herbicide resistance in tobacco ALS, and that double mutation of Ala121and Ser652 by Thr can confer stronger tolerance to Londax, Cadre, and TP.
Journal ArticleDOI

Role of Tryptophanyl Residues in Tobacco Acetolactate Synthase

TL;DR: Results indicate that the Trp490 residue is essential for the binding of FAD and that Trp573 is located at the herbicide binding site and suggest that the three classes of herbicides bind ALS competitively.
Journal ArticleDOI

Improvement of a rapid diagnostic application of monoclonal antibodies against avian influenza H7 subtype virus using Europium nanoparticles.

TL;DR: Novel monoclonal antibodies against influenza A H7N9 recombinant hemagglutinin (rHA)1 were developed and applied to a Europium nanoparticle–based rapid fluorescent immunochromatographic strip test (FICT) to improve the sensitivity of the rapid diagnostic system.
Journal ArticleDOI

Evaluation of a rapid diagnostic test, NanoSign® Influenza A/B Antigen, for detection of the 2009 pandemic influenza A/H1N1 viruses

TL;DR: As the NanoSign® Influenza A/B kit showed relatively high sensitivity and specificity and the good correlation with RT-PCR, it will be very useful in the early control of influenza infection and in helping physicians in making early treatment decisions.